Asthma, ECMO and eosinophils
- 25 January 2021
- Vol. 76 (7), 737-739
- https://doi.org/10.1136/thoraxjnl-2020-216052
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Exacerbations of severe asthma in patients treated with mepolizumabEuropean Respiratory Journal, 2018
- The Immunomodulatory Effects of Macrolides—A Systematic Review of the Underlying MechanismsFrontiers in Immunology, 2018
- Extracorporeal membrane oxygenation for life-threatening asthma refractory to mechanical ventilation: analysis of the Extracorporeal Life Support Organization registryCritical Care, 2017
- Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trialThe Lancet, 2017
- Neutrophil extracellular traps are associated with inflammation in chronic airway diseaseRespirology, 2016
- IL-6 trans-signaling increases expression of airways disease genes in airway smooth muscleAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2015
- Anti-inflammatory deficiencies in neutrophilic asthma: reduced galectin-3 and IL-1RA/IL-1βRespiratory Research, 2015
- Mepolizumab Treatment in Patients with Severe Eosinophilic AsthmaThe New England Journal of Medicine, 2014
- Potentially Pathogenic Airway Bacteria and Neutrophilic Inflammation in Treatment Resistant Severe AsthmaPLOS ONE, 2014
- The effects of IL-6 on CD4 T cell responsesClinical Immunology, 2009